Skip to main content
Clinical Trials/KCT0004373
KCT0004373
Completed
未知

Effect of micronized acellular dermal matrix on wound healing and granulation tissue formation in delayed wounds of diabetic foot ulcer patients.

Ajou University Hospital0 sites29 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the skin and subcutaneous tissue
Sponsor
Ajou University Hospital
Enrollment
29
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Acellular dermal matrix has been successfully used to heal diabetic foot ulcers. While conventional sheet-type dermal matrix promises wound healing, we report on our study to examine the clinical outcomes of a ready-to-use micronized dermal matrix for diabetic foot ulcers, comparing that with conventional negative pressure wound therapy. This was a prospective, randomized, pilot study of comparing micronized human acellular dermal matrix as an adjunctive treatment for diabetic foot ulcers that required operative debridement with conventional negative pressure wound therapy only. We randomly allocated 30 diabetic foot wounds of Wagner grade 2 or higher in 30 adult patients into 1 of 2 groups. The control group (n=15) was treated with conventional negative pressure wound therapy, and the experimental group (n=15) was treated with micronized dermal matrix and negative pressure wound dressing. We evaluated outcomes included granulation tissue formation, proportion of patients with closed or covered wound at 42 days and at 120 days, achieving complete wound healing during six months of follow-up, and intervals from enrollment to final surgical procedures. One patient in the conventional therapy group withdrew two days after enrollment due to major amputation. All 15 wounds treated with micronized matrix showed healthy granulation tissue without noticeable complications during follow-up. At 42 days, 46.7% of the experimental group had closed compared with 28.6% in the conventional therapy group (p = 0.007). At 120 days, 86.7% of the experimental group had closed completely compared with 57.1% in the conventional therapy group (p = 0.040). During the six-month follow-up period, 93.3% of the experimental group achieved complete wound healing compared with 85.7% of the conventional therapy group (p = 0.468). The healing outcomes in the experimental group were accelerated when combined with the use of negative pressure therapy.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Ajou University Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who are 18 years of age or older
  • 2\. Patients who had diagnosis of type 1 or type 2 diabetes with at least one nonhealing neuropathic or vasculopathic foot ulcer that failed following a minimum of four weeks of conservative care prior to study enrollment.
  • 3\. Patients who have foot ulcers of stage 2 or higher on Wagner’s scale and require operative intervention.
  • \* If a single patient had multiple wounds, we selected the deepest wound.
  • 4\. Subjects who have agreed to participate in this clinical trial

Exclusion Criteria

  • 1\. inadequate nutrition as assessed by a blood sample of serum albumin with a value less than 2\.0 g/dL
  • 2\. malignancy
  • 3\. autoimmune disease
  • 4\. using long\-term corticosteroids or immunosuppressants
  • 5\. uncontrolled hyperglycemia (preoperative HbA1c \>15\.0%)
  • \* patients who had undergone amputation above the level of the study wound.

Outcomes

Primary Outcomes

Not specified

Similar Trials